These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2207009)

  • 1. Blood transfusion in the para-Bombay phenotype.
    Lin-Chu M; Broadberry RE
    Br J Haematol; 1990 Aug; 75(4):568-72. PubMed ID: 2207009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal testing leading to the identification of B
    Mohan G; Vaidya A; Shastry S
    Immunohematology; 2021 Jun; 37(2):59-63. PubMed ID: 34170641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group discrepancy in A
    Bhagavathi MS; Das N; Prakash S; Sahu A; Routray S; Mukherjee S
    Immunohematology; 2021; 37(4):160-164. PubMed ID: 34964314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
    De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion practice blind spot in para-Bombay: A case report.
    Abdullah MR; Faizli AA; Noordin SS; Lee CJ; Ahmad NH
    Transfus Apher Sci; 2021 Jun; 60(3):103076. PubMed ID: 33574008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of anti-H in an individual with the Oh (Bombay) phenotype.
    Davey RJ; Tourault MA; Holland PV
    Transfusion; 1978; 18(6):738-42. PubMed ID: 726022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABO incompatibility with red blood cell indices of cord blood unit.
    Chen SH; Lin M; Yang KL; Lin TY; Tsai HH; Yang SH; Chang YH; Wu YF; Wang TF
    Pediatr Neonatol; 2012 Apr; 53(2):138-43. PubMed ID: 22503262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nondeletional ABO*O alleles frequently cause blood donor typing problems.
    Wagner FF; Blasczyk R; Seltsam A
    Transfusion; 2005 Aug; 45(8):1331-4. PubMed ID: 16078922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of 59Fe-labeled erythrocytes in cross-transfused equine blood.
    Kallfelz FA; Whitlock RH; Schultz RD
    Am J Vet Res; 1978 Apr; 39(4):617-20. PubMed ID: 646196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation.
    Hult AK; Dykes JH; Storry JR; Olsson ML
    Transfus Med; 2017 Jun; 27(3):181-191. PubMed ID: 28401678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study.
    Zeller MP; Barty R; Aandahl A; Apelseth TO; Callum J; Dunbar NM; Elahie A; Garritsen H; Hancock H; Kutner JM; Manukian B; Mizuta S; Okuda M; Pagano MB; Pogłód R; Rushford K; Selleng K; Sørensen CH; Sprogøe U; Staves J; Weiland T; Wendel S; Wood EM; van de Watering L; van Wordragen-Vlaswinkel M; Ziman A; Jan Zwaginga J; Murphy MF; Heddle NM; Yazer MH;
    Transfusion; 2017 Oct; 57(10):2329-2337. PubMed ID: 28840943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characteristics and clinical significance of anti-H in the Ah phenotype.
    Whitsett CF; Cobb M; Pierce JA; Parvin M
    Transfusion; 1984; 24(2):164-5. PubMed ID: 6710589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of ABO Blood Group Incompatible Fetal Red Blood Cells in the Maternal Circulation: Relevance to the Diagnosis of Fetal-Maternal Hemorrhage.
    Dana M; Fibach E
    Neonatology; 2018; 114(4):303-306. PubMed ID: 30011398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgent replacement of a mechanical mitral prosthesis in an anticoagulated patient with Bombay red blood cell phenotype.
    Nairn TK; Giulivi A; Neurath D; Tokessy M; Sia YT; Ruel M; Wilkes PR
    Can J Anaesth; 2010 Jun; 57(6):583-7. PubMed ID: 20306240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New variants of the blood groups ABO (H) caused by interaction of recessive genes, directing the formation of H antigen in erythrocytes: phenotype Bombay-like variants O Hm, O B Hm, O AB Hm].
    Hrubisko M; Laluha J; Mergancová O; Zákovicová S
    Vnitr Lek; 1970 Jun; 16(6):577-85. PubMed ID: 5527454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serological Characteristics and Family Survey of 3 Cases of H-deficient Blood Group].
    Geng W; Gao HH; Zhang LW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):913-7. PubMed ID: 27342532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.